<DOC>
	<DOCNO>NCT01080443</DOCNO>
	<brief_summary>The objective study compare bioavailability characterise pharmacokinetic profile Mycophenolate mofetil 250 mg capsule Panacea Biotech Ltd , India Cellcept® 250 mg capsule Mycophenolate mofetil capsule , Roche Labs Inc. New Jersey , USA normal , healthy , adult human subject fast condition , assess bioequivalence .</brief_summary>
	<brief_title>Bioequivalence Study Mycophenolate Mofetil 250 mg Capsule Under Fasting Condition</brief_title>
	<detailed_description>48 +8 ( stand-by ) normal healthy adult subject enrol study . Subjects administer either Test Reference Product 240 mL water period per randomization schedule . Subjects fast least 10 hour prior dose administration least 4 hour post dose . Standardized meal provide study period . Water accessible subject 1 hour Predose 2 hour Post dose period . A total 28 blood sample withdraw pharmacokinetic profiling . The concentration mycophenolate mofetil mycophenolic acid quantitated use validate LC-MS / MS method.ANOVA , two one-sided test bioequivalence , power ratio analysis un-transformed ln-transformed pharmacokinetic parameter Cmax , AUC0-t AUC0-inf compute report Mycophenolic acid . Bioequivalence test product reference product fast condition conclude 90 % confidence interval fall within acceptance range 80.00-125.00 % ln-transformed pharmacokinetic parameter Cmax , AUC0-t AUC0-inf Mycophenolic acid .</detailed_description>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Normal , healthy human volunteer 18 60 year age ( inclusive ) live around Ahmedabad city western part India . Having Body Mass Index ( BMI ) 18.5 24.9 ( inclusive ) , calculate weight kg / height m2 . Not significant disease clinically significant abnormal finding screen , medical history , physical examination , laboratory evaluation , 12 lead ECG Xray chest ( posteroanterior view ) recording . Able comply study procedure , opinion Principal Investigator . Able give write consent participation trial . In case female subject must ( A ) Surgically sterilize least 6 month prior study participation ( B ) Those child bear potential must use suitable effective double barrier contraceptive method intra urine device study . Known hypersensitivity idiosyncratic reaction Mycophenolate Mofetil related drug . Any disease condition might compromise haemopoietic , renal , hepatic , endocrine , pulmonary , central nervous , cardiovascular , immunological , dermatological , gastrointestinal body system . Ingestion medicine time 14 day start study . In case subject selection discretion Principal Investigator / Medical Expert . Any history presence asthma ( include aspirin induce asthma ) nasal polyp nonsteroidal antiinflammatory drug ( NSAID ) induce urticaria . A recent history alcoholism ( &lt; 2 year ) moderate ( 180 mL / day ) alcohol use , consumption alcohol within 48 hour prior receive study medicine . Smokers , smoke 10 cigarette per day / unable abstain smoking study . The presence clinically significant abnormal laboratory value screen . Use recreational drug history drug addiction test positive pre study drug scan . History psychiatric disorder . A history difficulty donate blood . Donation blood ( 1 unit 350 mL ) within 90 day prior receive first dose study medicine . Note : In case blood loss ≤ 200 mL , subject may dose 60 day blood donation . A positive hepatitis screen include hepatitis B surface antigen antihepatitis C virus ( HCV ) antibody . A positive test result antiHIV antibody / syphilis . The receipt investigational product participation drug research study within period 90 day prior first dose study medicine . Elimination halflife study drug take consideration inclusion subject study . Note : If subject participate study blood loss ≤ 200 mL , subject dose 60 day last sample previous study . An unusual diet , whatever reason ( e.g . lowsodium ) , four week prior receive study medication throughout subject 's participation study . In case subject selection discretion Principal Investigator / Medical Expert . Pregnant female Nursing mother Testing positive urine pregnancy test .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Bioequivalence study healthy volunteer</keyword>
</DOC>